We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-1.68%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.43B
AUM Growth
+$172M
Cap. Flow
+$215M
Cap. Flow %
15.04%
Top 10 Hldgs %
3.57%
Holding
2,136
New
582
Increased
568
Reduced
423
Closed
559

Top Sells

Rank Stock Value
1
JBSS icon
John B. Sanfilippo & Son
JBSS
+$3.41M
2
APA icon
APA Corp
APA
+$3.31M
3
ZTS icon
Zoetis
ZTS
+$3.2M
4
UGI icon
UGI
UGI
+$3.03M
5
DOCU
DocuSign
DOCU
+$2.87M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Healthcare 13.4%
3 Consumer Discretionary 13.25%
4 Financials 12.49%
5 Industrials 11.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BWEN icon
1126
Broadwind
BWEN
$109M
$388K 0.03%
118,287
-56,711
-32% -$169K
GSAT icon
1127
Globalstar
GSAT
$10.8B
$387K 0.03%
23,035
+20,770
+917% +$374K
WB icon
1128
Weibo
WB
$1.95B
$387K 0.03%
+50,383
New +$439K
DRRX
1129
DELISTED
DURECT Corp
DRRX
$386K 0.03%
299,505
+57,836
+24% +$68.1K
ARCC icon
1130
Ares Capital
ARCC
$14.4B
$384K 0.03%
+18,427
New +$385K
GNTX icon
1131
Gentex
GNTX
$5.07B
$384K 0.03%
11,402
-11,905
-51% -$411K
HLF icon
1132
Herbalife
HLF
$1.29B
$384K 0.03%
+36,988
New +$370K
PAYS icon
1133
Paysign
PAYS
$705M
$384K 0.03%
+89,199
New +$393K
DAR icon
1134
Darling Ingredients
DAR
$9.44B
$383K 0.03%
10,429
-6,267
-38% -$260K
LPLA icon
1135
LPL Financial
LPLA
$28.6B
$383K 0.03%
1,373
+50
+4% +$13.6K
XLI icon
1136
State Street Industrial Select Sector SPDR ETF
XLI
$33.7B
$382K 0.03%
+3,135
New +$386K
SRTA
1137
Strata Critical Medical Inc
SRTA
$512M
$381K 0.03%
109,438
-174,286
-61% -$581K
AZN icon
1138
AstraZeneca
AZN
$250B
$380K 0.03%
+2,436
New +$367K
MG icon
1139
Mistras Group
MG
$512M
$380K 0.03%
45,835
+33,740
+279% +$295K
TPL icon
1140
Texas Pacific Land
TPL
$23.5B
$380K 0.03%
+1,551
New +$325K
OCFC icon
1141
OceanFirst Financial
OCFC
$1.91B
$379K 0.03%
23,857
-47,847
-67% -$723K
T icon
1142
AT&T
T
$163B
$377K 0.03%
+19,724
New +$343K
CVI icon
1143
CVR Energy
CVI
$3.13B
$376K 0.03%
+14,038
New +$426K
EGBN icon
1144
Eagle Bancorp
EGBN
$845M
$375K 0.03%
19,827
-27,789
-58% -$541K
ATI icon
1145
ATI
ATI
$31B
$374K 0.03%
+6,742
New +$378K
IREN icon
1146
Iris Energy
IREN
$14.7B
$373K 0.03%
+33,047
New +$248K
LRMR icon
1147
Larimar Therapeutics
LRMR
$432M
$373K 0.03%
51,424
+22,362
+77% +$171K
PINS icon
1148
Pinterest
PINS
$13.4B
$373K 0.03%
8,462
-12,683
-60% -$500K
SILK
1149
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$373K 0.03%
+13,805
New +$287K
POWW icon
1150
Outdoor Holding Co
POWW
$247M
$371K 0.03%
+221,076
New +$532K

Similar funds

GSA Capital Partners's Q2 2024 Portfolio in Review

As of Q2 2024, GSA Capital Partners held 2,136 positions worth $1.43B, up 14% from $1.26B the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.

GSA Capital Partners deployed $215M of net new capital in Q2 2024, opening 582 new positions and adding to 568 existing holdings. Its largest new stake was Genuine Parts: 28,253 shares worth $3.91M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was UGI, an estimated $3.03M trimmed.

  • GSA Capital Partners's largest Q2 2024 buy was Genuine Parts: 28,253 shares worth $3.91M.
  • GSA Capital Partners added most to Devon Energy in Q2 2024, an estimated $5.97M increase.
  • GSA Capital Partners's biggest Q2 2024 reduction was UGI, cutting an estimated $3.03M.
  • GSA Capital Partners fully exited John B. Sanfilippo & Son in Q2 2024, selling an estimated $3.41M.
  • GSA Capital Partners's ten largest holdings make up 3.6% of its $1.43B portfolio in Q2 2024.
  • GSA Capital Partners opened 582 new positions and closed 559 in Q2 2024.
  • GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $1.43B.

Based on GSA Capital Partners's 13F filing for Q2 2024, filed 15 Aug 2024.